Leading the way to safer medication
 Crosscheck  Recommender

Betamethasone

Brand names: ANTASONE (in combination) B-TASONE-G (in combination) BESONE BETACORT (in combination) BETACYLIC (in combination) BETADERM BETAFUSIN (in combination) BETASONE BETEFLAM BETESIL BETNESOL BETNOVATE BETOSALIC (in combination) CAMNOVATE CELESTAN BIPHASE (in combination) CELESTONE SOLUSPAN (in combination) DEFUZIN-B (in combination) DERMANOL-C (in combination) DERMASONE DIPROCEL DIPROSPAN (in combination) DOVOBET (in combination) FUCIBET (in combination) FUCICORT (in combination) FUSICUTAN (in combination) LUXIQ MEDOBETA MOVITHIOL OSMORAN READYSHARP BETAMETHASONE (in combination) SENSIBIO (in combination) SODERM (in combination) SYNMETHASONE TEMPROSONE TRI-MICON (in combination) UNIFLEX UNIFLEX-N VALISONE-G (in combination)

Therapeutic Indications

Betamethasone is indicated for:

Severe shock

Irrespective of gender only Children (1 year - 12 years old)

Severe shock arising from surgical or accidental trauma or overwhelming infection.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 2-4 mg

Status asthmaticus, acute allergic reactions

Irrespective of gender only Children (1 year - 12 years old)

Status asthmaticus and acute allergic reactions, including anaphylactic reactions to drugs.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 2-4 mg

Irritant contact dermatitis, allergic contact dermatitis

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Discoid lupus erythematosus

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Atopic dermatitis

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

Atopic dermatitis (including infantile atopic dermatitis).

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Generalised erythroderma

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

Adjunct to systemic steroid therapy in generalised erythroderma.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Insect bite reactions

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Seborrhoeic dermatitis

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Lichen simplex chronicus, lichen planus

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

Lichen simplex chronicus (neurodermatitis) and lichen planus.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Treatment 2: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Prurigo nodularis

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Discoid eczema

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Psoriasis

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

Psoriasis (excluding widespread plaque psoriasis).

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Cutaneous - 1-2 spreads in 1-2 divided doses daily

Acute adrenal crisis

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

Acute adrenal crisis caused by abnormal stress in Addison’s disease, Simmonds' disease, hypopituitarism following adrenalectomy, and when adrenocortical function has been suppressed by prolonged corticosteroid therapy.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 2-4 mg

Severe shock

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

Severe shock arising from surgical or accidental trauma or overwhelming infection.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-20 mg

Treatment 2: Intramuscular - 4-20 mg

Tennis elbow, tenosynovitis, bursitis

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

Soft tissue lesions such as tennis elbow, tenosynovitis and bursitis.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-20 mg

Treatment 2: Intramuscular - 4-20 mg

Status asthmaticus, acute allergic reactions

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

Status asthmaticus and acute allergic reactions, including anaphylactic reactions to drugs.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-20 mg

Treatment 2: Intramuscular - 4-20 mg

Acute adrenal crisis

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

Acute adrenal crisis caused by abnormal stress in Addison’s disease, Simmonds' disease, hypopituitarism following adrenalectomy, and when adrenocortical function has been suppressed by prolonged corticosteroid therapy.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-20 mg

Treatment 2: Intramuscular - 4-20 mg

Contraindications

Active ingredient Betamethasone is contraindicated in the following cases:

Systemic infections

No gender/age discrimination

Systemic infections, unless specific anti-infective therapy is employed.